Lutronic and Syneron-Candela Settle Lawsuit

Syneron Medical Ltd and Candela Corporation, and Lutronic Corp and Lutronic Aesthetics Inc, announce that they have entered into a mutually agreeable comprehensive settlement agreement ending the patent disputes between the companies.

Terms of the settlement agreement were not disclosed.

The mutually agreed-upon settlement, limited to Lutronic, protects Candela’s investment in Profound and its patented long pulse and temperature-controlled technology today and in the future. The settlement, through a sublicense from Syneron-Candela, allows Lutronic to market its product in the short pulse category, protecting Candela’s investment in the development of products in the long pulse category with a thermocouple.

For more information, read the full news release at

Galderma Forms Advisory Council to Support Women in Aesthetics

Galderma Laboratories LP announces the formation of the Women in Aesthetics Leadership Council.

The new multi-disciplinary group of advisory council members, comprised of distinguished current and future female leaders in the field of medical aesthetics, is committed to working together to empower women across the nation to succeed.

“In most industries in the US women hold just 25% of senior leadership positions, lagging significantly behind their male counterparts, while women in the healthcare field hold 49% of these top posts,” says Alisa Lask, vice president and general manager of the US Aesthetic Business, in a media release from Galderma.

“Our goal is to accelerate the trend of women holding leadership roles in medical societies, conducting clinical research, supporting training organizations, and to foster support for female-focused aesthetic business ownership.”

The Women in Aesthetics Leadership Council is comprised of clinicians, clinical trial investigators, CEOs, business owners, and practice managers. These current and emerging female leaders in the aesthetics industry recently served as expert consultants in a series of advisory boards in key markets across the country where Council members gave feedback on their experiences and ideas, offering insights that will guide the development of programs and resources to support female-led practices, businesses ,and research projects, the release continues.

“I am honored to be part of this select group of leaders who are passionate about increasing opportunities for women’s advancement in aesthetics,” states Sheila Nazarian, MD, MMM, founder of Nazarian Plastic Surgery.

“Our mission is to develop and share valuable approaches that open doors for a new generation of female leaders across the industry while also enhancing skill sets of members in this Council so that we all reach our greatest potential together,” she adds.

The foundation of the Women in Aesthetics Leadership Council is the first step in building a shared vision, collaborating to execute practical solutions and creating a strong roadmap for future leadership in medical aesthetics. Galderma’s focus on this initiative underscores its ongoing commitment to invest in innovations that drive meaningful and sustained impact for providers and ultimately enhance positive patient outcomes, the company notes in the release.

[Source(s): Galderma, PR Newswire]

AAFPRS Survey Reveals Key Trends In Facial Plastic Surgery

The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual survey results for 2018. The annual survey explores the top trends in facial plastic surgery today.

This year’s findings indicate a strong link between Millennials (now 22-37 years old) and the growing demand for cosmetic procedures. The average number of surgical procedures has almost doubled since 2013 (up 47 percent) with a 22 percent increase in Botox injections compared to 2013, revealing that facial tweaks and treatments continue to be embraced and are sought after at a marathon pace.

AAFPRS members note that there is more emphasis on early care or pre-juvenation in the 20’s and 30’s and that technology — both in the physician’s office and at home — plays a key role in confidence, explains a media release from AAFPRS.

For more information, and to read the full press release, visit AAFPRS.

Obalon Scores Funding on the Heels of Obesity Market Shift

Two new funding deals could give Obalon the added firepower needed for it to more effectively compete in the obesity treatment market.

The San Diego-based company said it has garnered $30 million from a stock purchase agreement with Lincoln Park Fund and an At-the-market equity sales agreement with Canaccord Genuity. The agreement with Lincoln Park Fund would net up to $20 million while the firm’s agreement with Canaccord Genuity could help bring in about $10 million.

Obalon said it could use the proceeds for sales and marketing costs, clinical studies, research and development costs, manufacturing development, the acquisition or licensing of other businesses or technologies, repayment and refinancing of debt, working capital and capital expenditures.

Read the full article at

Are Barriers Steering Minority Med Students Away from Dermatology?

Minority medical students perceived a number of factors as deterring them from pursuing careers in dermatology, according to survey results.

One was the current lack of diversity in dermatology, according to Yssra Soliman, BA, of Albert Einstein College of Medicine in Bronx, New York, and colleagues in JAMA Dermatology. They noted that African-Americans and Hispanics each make up less than 5% of practicing dermatologists, far less than their proportions in the general population.

Read the full article at

Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration

X-Chem Inc (X-Chem) announces a drug discovery partnership with Almirall S.A. (Almirall) to discover lead compounds for innovative and challenging targets with dermatology applications.

Under the terms of the agreement, X-Chem will utilize its DNA-encoded library (DEX) screening platform and proprietary informatics tools to search for novel hits for Almirall targets. X-Chem’s DEX libraries enable the screening of vast areas of drug-like chemical space, and support Almirall’s goal of identifying drug-like leads with shorter development timelines.

Almirall will assess the biochemical and/or cellular activity, novelty, and in some cases advanced properties of the leads identified under the collaboration. Almirall has the option to license these drug leads, and will be responsible for further development and commercialization of the resulting programs, explains a media release from X-Chem Inc.

“This agreement takes us one step further in our goal of becoming a leading medical dermatology company. With the cutting edge technology offered by X-Chem and our strong knowledge of the area of dermatology, we will be able to broaden our pipeline and provide further medical solutions for the physicians and patients, specially designed for dermatological diseases with unmet medical needs,” says Bhushan Hardas, MD, MBA, chief scientific officer of Almirall.

“The treatment of dermatological diseases is an important field of research with unmet medical needs. We are delighted to align with Almirall, a leader in the field, to apply our DEX platform to the discovery of new treatments for patients worldwide,” states Rick Wagner, president and CEO of X-Chem, the release continues.

[Source(s): X-Chem Inc, Business Wire]

ABCS Questions Decision Limiting Surgeons’ Right to Advertise Their Board Certification

On December 18th, 2018, the Medical Board of California (MBC) denied the rights of exceptionally trained surgeons to advertise their board certification after they demonstrated that they meet every criteria required to state their board certification, according to a media release.

“The American Board of Cosmetic Surgery (ABCS) is the only certifying board dedicated exclusively to the specialty of cosmetic surgery,” states Peter Canalia, Esq, executive director ABCS, in a media release. “We are disappointed in their decision to support legislation that limits patient choice and is a clear violation of commercial free speech and antitrust and anti-competitive laws.”

For more information, read the full press release at

RealSelf Forms Strategic Medical Advisory Council

RealSelf Inc announces it has formed a Strategic Medical Advisory Council with three operating boards that will infuse medical expertise and feedback into its operations to strengthen the value of RealSelf products, services, and content and further support its mission to help consumers make smart, confident decisions.

The Real Self Strategic Advisory Council is made up of the Business Advisory Board, the Medical Review Advisory Board and the Industry Advisory Board, all of which are comprised of board-certified doctors and surgeons who are leaders in their fields and active proponents of transparency and the evolution of aesthetics. The formation of the council follows the appointment of the first RealSelf Chief Medical Officer last summer, according to a media release from RealSelf.

“As a fast-moving technology company in the rapidly changing aesthetics industry, it is imperative we keep our ear to the ground to stay ahead of trends to best serve the needs of consumers and doctors. Doctor feedback has always been a valuable part of our evolution, and I am incredibly excited to formalize the Council as part of our operations to ensure we are best serving the needs of our consumers and medical practitioners for decades to come,” says Tom Seery, co-founder and CEO of RealSelf, in the release.

“These doctors are forward-looking leaders in their fields and will help RealSelf better understand historical industry challenges, evaluate what we plan to bring to market, and envision the aesthetics landscape of the future. We’re honored to welcome them to the RealSelf team.”

The Business Advisory Board charter is to work alongside RealSelf senior leadership, influencing product and business decisions that affect the RealSelf community, which includes consumers interested in cosmetic procedures and doctors and other medical professionals.

For more information, read the full press release at

The Aesthetic Society Unveils 2019 Plastic Surgery Predictions

The American Society for Aesthetic Plastic Surgery (The Aesthetic Society/ASAPS) has released its 2019 predictions detailing what plastic surgery trends are expected in the coming year.

Insight from its members includes specific trends for surgical and non-invasive options, and a topline forecast for the next decade including less emphasis on celebrity emulation and more emphasis on a tailored, individual look, explains a media release from ASAPS.

“Next year also promises a surge of significant technological advancements for aesthetic procedures geared at skin resurfacing, body contouring, skin tightening, and more,” says W. Grant Stevens, MD, FACS, president of the Aesthetic Society, in the release.

“Our predictions provide foresight into new developments that fulfill the consumer’s desire for minimally invasive solutions, as well as modern techniques for the surgical gold standards, minimizing downtime, improving outcomes, and reaching a broader audience.”

2019 Predictions

Celebrity Feature Requests Dwindle in Favor of Social Media Filters:

  • ASAPS surgeons say while they still have requests for Meghan Markle’s nose and Kylie Jenner’s lips, the requests for celebrity features has dropped off substantially and more patients want to look like the best version of themselves.
  • Many patients are referencing their own filtered selfies for their aesthetic aspirations—requesting to look the way they do through filters on Instagram and Facetune (an app that allows users to edit portraits and selfies with image-enhancing retouching tools).

Desire for Subtle, Conservative Outcomes:

  • Many Aesthetic Society members say plastic surgery is trending towards refined, subtle results versus the sculpted glam or “overdone” look.
  • The trend toward conservative options creates a renewed interest in smaller breast implants (or even explantation) and non-implant-based breast augmentation. ASAPS data reflects these emerging trends with fat transfer to the breast increasing (up 41.4%) and fat transfer to the face (up 16.7%).

The Next 10 Years:

  • An increase in surgical procedures with industry advances allowing for less invasive techniques and limited downtime.
  • Patients will be more open to surgical procedures as they can achieve the longest or sometimes permanent results.
  • Modern improvements like minimally invasive face and neck lifts and procedures done under local anesthesia will draw greater numbers of patients to consider surgical options.

Also Likely to Trend in 2019:

Millennials Entering the Aesthetic Market:

  • Marketing to Millennials will also evolve as more flock to social media for plastic surgery information and a shift to subscription-based services will grow.

Plastic Surgery Among Men:

  • High-definition abdominal liposculpting (liposuction and body sculpting with fat transfer) will likely continue to rise in popularity next year as men seek solutions for their ideal physique.

RealSelf Debuts Hall of Fame to Honor Ratings and Education

RealSelf Hall of Fame Unveiled

RealSelf announces the debut of the RealSelf Hall of Fame, an honor recognizing more than 1,000 board-certified aesthetic doctors from 402 cities across the United States, the United Kingdom, Canada, and Australia for their high patient ratings and commitment to consumer education.

For 8 years, the annual RealSelf 100 and 500 awards recognized doctors with outstanding records of high patient ratings who have given back to the RealSelf community by providing credible, valuable insights in response to consumer questions about elective cosmetic treatments ranging from surgical procedures to minimally invasive technologies to cosmetic dentistry. For the first time ever, RealSelf celebrates the Hall of Fame, a culmination of 8 years of recognitions made through the RealSelf 100 and 500 awards program, according to RealSelf in a media release.

“Making the RealSelf Hall of Fame requires a commitment to helping patients make informed and confident choices,” says Dr Lara Devgan, RealSelf chief medical officer and board-certified plastic surgeon, in the release. “From answering consumer questions and sharing before and after photos to encouraging patients to leave open and honest reviews, the valuable insights this group provides help make it possible for RealSelf to bring transparency to the medical aesthetics industry.”

To be included in the RealSelf Hall of Fame, doctors must have received a RealSelf 100 or RealSelf 500 award in the past, the release explains. The awards program, which first launched in 2010, honors the top-rated and most engaged board-certified aesthetic doctors on RealSelf. Doctors are ranked in three categories: earning patient reviews, answering consumer questions, and sharing before and after treatment photos. In order to be recognized in any given year, doctors must maintain the distinction of Top Doctor or Top Contributor and uphold an average rating above four stars.

“The RealSelf Hall of Fame honors the achievements of board-certified aesthetic doctors who consistently put the consumer first,” states Tom Seery, founder and CEO of RealSelf. “It’s my pleasure to recognize this elite group of doctors for their significant contributions on RealSelf and their high standards in patient satisfaction.”

“As RealSelf grows and continues to evolve how we help consumers make smart and confident decisions, we are also evaluating how we recognize our medical community,” Seery adds. “We look forward to announcing new plans for RealSelf awards and recognitions in 2019.”

[Source(s): RealSelf, PR Newswire]